Application 761270

Type
BLA
Sponsor
ASTRAZENECA AB

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001IMJUDOTREMELIMUMAB-ACTLINJECTABLE;INTRAVENOUS, SUBCUTANEOUS25MG/1.25ML(20MG/ML)NoNo
002IMJUDOTREMELIMUMAB-ACTLINJECTABLE;INTRAVENOUS, SUBCUTANEOUS300MG/15ML(20MG/ML)NoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
74263ORIG 2023-05-16
72610ORIG2022-11-14
72603ORIG2022-11-13
72602ORIG2022-11-13